Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-18-050839

Director bought 1,604 shares at $2.35 ($3,769)

From the SEC's structured data for this filing

Trades in this filing

ANDREWS DEBORAH J · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-09-11 Purchase : show line 1 in the form +1,604 $2.35 $3,769 10,000 D
Open-market purchases · 1,604 sh · avg $2.35 · $3,769
Loading xslF345X03/doc4.xml…